We are delighted to see the MD Anderson Cancer Center, ranked number one in the nation for cancer care, specifically citing scrambler therapy as a pain management solution to combat chronic nerve pain after chemotherapy treatment (CIPN): https://www.mdanderson.org/cancerwise/peripheral-neuropathy–causes–symptoms-and-treatments.h00-159621012.html
Scrambler therapy – Scrambler therapy mixes up the pain signals to only permit normal, non-pain signals to be transmitted to the brain. Electrode patches are placed on the skin around the area where the patient is experiencing pain. The patches are tethered to a machine that sends electrode pulses to the area to interfere with the pain signal, which then reduces the pain sensation the patient perceives. Overall, we’ve seen a significant increase in patients’ quality of life. Patients have reported experiencing less pain, and others have also had sensation return where they had previously had numbness. MD Anderson has been pivotal in studying scrambler therapy, but it’s still not as widely available as I’d like to see.
What is chemotherapy-induced peripheral neuropathy (CIPN)?
CIPN is caused by the heavy metals used in chemotherapy medications which strive to eradicate cancer cells, but may also cause significant nerve damage in the process. If post-treatment nerve pain should result, it can significantly diminish the cancer warrior’s quality of life–even after the cancer is gone.
A combination of studies has found that more than 50 percent of chemo patients suffer from CIPN, a tremendously painful condition that is famously difficult to treat with traditional medication, most commonly Cymbalta, Lyrica, or Gabapentin.
How does Calmare scrambler therapy help combat CIPN pain?
However, several recent studies found that non-invasive and drug-free scrambler therapy can significantly reduce chemotherapy symptoms (CIPN), even when symptoms have been present for more than one year.
Additional clinical studies by several research institutions, including the University of Wisconsin, the Massey Cancer Institute, and the Mayo Clinic found that Calmare’s scrambler therapy produces significantly positive results in minimizing or even eliminating pain from chemotherapy treatment.
“The US Food and Drug Administration (FDA) specifically cleared the Calmare MC-5A device to treat patients with neuropathy as a result of chemotherapy,” says Calmare clinical director Dr. Michael Cooney.
“We have successfully treated patients with CIPN since 2011 and have seen sustained pain management outcomes for the majority of patients.”
These findings, reported by top U.S. cancer centers, serve as a light at the end of a long, dark tunnel of pain for our friends, family and colleagues living with the painful after-effects of chemotherapy treatment.
Contact Calmare NJ USA for your no-fee consultation related to post-chemotherapy nerve pain or any treatment-resistant neuropathy by calling (201) 933-4440 or email us privately to speak directly with Dr. Cooney.